Table 5. Renal outcomes between the patient groups.
Variables | Fixation type | p | |||||
Suprarenal (n=114) | Infrarenal (n=54) | ||||||
n | % | Mean±SD | n | % | Mean±SD | ||
Baseline insufficiency (sCr >1.5 mg/dL) | 6 | 5.3 | 2 | 3.7 | 0.660 | ||
Post-EVAR renal impairment (>30%) | |||||||
Change in sCr level | 57 | 50 | 28 | 51.9 | 0.824 | ||
Change in MDRD | 53 | 46.5 | 26 | 48.1 | 0.842 | ||
Change in Crockcroft-Gault | 50 | 43.9 | 20 | 37 | 0.405 | ||
Change in CKD-EPI | 33 | 28.9 | 15 | 27.8 | 0.876 | ||
Hemodialysis | 2 | 1.8 | 0 | 0 | 0.330 | ||
Contrast volume (mL) | 231±24.2 | 225±25.2 | 0.107 | ||||
Renal artery stenosis/stent | 2 | 1.8 | 0 | 0 | 0.330 | ||
Renal infarction | 3 | 2.6 | 1 | 1.9 | 0.759 | ||
Computed tomography (n) | 4.63±2.58 | 4.12±2.23 | 0.221 | ||||
SD: Standard deviation; EVAR: Endovascular aortic repair; MDRD: Modification of Diet in Renal Disease; sCr: Serum creatinine; CKD-EPI: Chronic Kidney Disease-Epidemiology Collaboration. |